DXCM vs ALGN — Key Metrics

Metric DXCM (DEXCOM INC) ALGN (ALIGN TECHNOLOGY INC)
Price82.52163.96
Market Cap30.78 Billion11.56 Billion
P/E (TTM)31.8623.83
P/B (Quarterly)11.7582.7
P/S (TTM)6.032.78
Net Profit Margin (TTM)19.411.8
Gross Margin (TTM)63.469.1
ROE (TTM)36.511.8
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

DEXCOM INC
vs
 
ALIGN TECHNOLOGY INC
 
DEXCOM INC
vs
 
ALIGN TECHNOLOGY INC
Performance Comparison
AI Model Recommendation
DXCM · DEXCOM INC

Outperform

13
UnderperformOutperform
ALGN · ALIGN TECHNOLOGY INC

Outperform

52
UnderperformOutperform
Recommendation Summary

Both stocks are projected to outperform the market over the next year. If you have to make a choice, Upfront Recommendation: ALGN.

Financial Metrics
Prices delayed ~15 min
DXCM Metrics ALGN
$82.52 Price $163.96
— Market Capitalization —
31.86 Price to Earnings Ratio 23.83
6.03 Price to Sales 2.78
28.02 Price to FCF Ratio 17.93
9.51 Price to Gross Profit 4.02
50.61 Price to R&D 30.61
7.86 Price to Current Assets 4.24

DXCM vs ALGN at a glance

Dexcom INC (DXCM) and Align Technology INC (ALGN) are both Medical Devices companies in the Healthcare sector. DXCM is the larger, at $30.8 billion in market value against $11.6 billion for ALGN, about 2.7 times the size.

On trailing-twelve-month figures, DXCM trades at 31.9 times trailing earnings and ALGN at 23.8; net profit margins are 19.4% and 11.8%.

The Upfront Investment model currently rates both Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.